28
Oct
2025

PRIME PHARMACEUTICALS PVT. LTD

Exhibitor at CPHI Frankfurt 2025 stand 3.1G67, Finished Dosage Formulations
About Us

Prime Pharma, founded in 1968, is an R&D-driven company with state-of-the-art manufacturing plants for orals, semisolids, beta-lactams & biosimilars. Following cGMP practices, our plants are inspected by global regulatory agencies. We offer contract research & manufacturing services and have a diverse portfolio in cardio-diabetics, CNS, immunology, Hematology, beta-lactams, anti-infectives and nutraceuticals. Key products include Liraglutide, Insulin Glargine, Tofacitinib & Eltrombopag. We are Devoted to Discovery & Committed to Care with exports to 50+ countries worldwide.

  • IN
  • 2018
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company
Primary activities
Biopharmaceutical
Contract Manufacturer
Nutraceuticals
OTC
Other
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Contact info
  • “B327/328”, 3rd floor, Chintamani Plaza,, Andheri Kurla Road Andheri (East),, 400099, MUMBAI, India
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 3.1G67, Finished Dosage Formulations